Currently Viewing:

What We're Reading: Gottlieb Discusses Drug Pricing; VA Chief Might Be Replaced; Opioid Data Hard to Use

AJMC Staff
FDA Commissioner Scott Gottlieb, MD discussed the agency's role in tackling drug prices in an interview; President Trump is considering firing the head of the VA; measuring the extent of the opioid crisis with available data is more difficult than it seems. 

Gottlieb Discusses FDA Role in Combatting High Drug Prices

FDA Commissioner Scott Gottlieb, MD, is the public face of the Trump administration’s effort to lower the cost of prescription drugs. In an interview with The Hill, he said getting involved in the drug pricing debate is part of the agency’s mission.  Separately, former congressman Henry Waxman spoke with Stat News about his thoughts regarding drug prices.  

Trump May Replace Shulkin at VA With Perry From Energy 

President Trump is considering firing David Shulkin, MD, the secretary of veterans affairs, in favor of Energy Secretary Rick Perry, according to The New York Times. The dispute stems from a struggle over the extent of privatization efforts at the VA, the largest integrated healthcare system in the United States, providing care at 1243 healthcare facilities to over 9 million veterans. Perry has no healthcare experience.

Using Available Data to Tally Opioid Crisis More Difficult Than Expected

An editor at ProPublica described his efforts to compile data on opioid prescribing, overdoses, deaths, and treatment options, but found the task more difficult than he expected. Making conclusions was difficult since data were out of date, hard to find, and/or contradicted other data, the report said. 

Related Articles

Patient Ratings of Veterans Affairs and Affiliated Hospitals
California Becomes the Latest State to Enact Drug Pricing Legislation
Bringing Care Coordination to the Fight for Recovery From Opioids
FDA's Gottlieb Blames Rebates, Reimbursement Issues for Holding Back Biosimilar Market
Drug Pricing Debate: Panel Talks About Transparency, Legislation
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up